Phase I and IIa trial of KW-0761 in patients with HAM

Trial Profile

Phase I and IIa trial of KW-0761 in patients with HAM

Phase of Trial: Phase I/II

Latest Information Update: 08 Feb 2018

At a glance

  • Drugs Mogamulizumab (Primary)
  • Indications Spinal disorders; Tropical spastic paraparesis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 08 Feb 2018 Results assessing safety, pharmacokinetics and efficacy published in the New England Journal of Medicine
    • 24 Sep 2015 Status changed from recruiting to active, no longer recruiting, as per University Hospital Medical Information Network - Japan record.
    • 06 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top